Welcome to our dedicated page for Alexandria Real Estate Eq news (Ticker: ARE), a resource for investors and traders seeking the latest updates and insights on Alexandria Real Estate Eq stock.
Alexandria Real Estate Equities, Inc. reports news as a life science real estate investment trust that owns, operates and develops collaborative Megacampus™ ecosystems in major life science innovation clusters. Company updates commonly cover operating results, funds from operations, leasing activity, rental-rate trends and property-market demand across locations such as Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle and New York City.
Recurring announcements also include quarterly common stock dividends, balance-sheet and liquidity commentary, capital recycling activity, senior note offerings, cash tender offers for outstanding debt and corporate governance or leadership matters tied to the REIT’s public-company structure.
Alexandria Real Estate Equities (NYSE: ARE) announced a public offering of senior notes, subject to market conditions. The notes will be unsecured obligations guaranteed by Alexandria Real Estate Equities, L.P. The net proceeds are primarily aimed at refinancing the outstanding 3.900% senior notes due 2023 and may also fund acquisitions, development projects, and reduce credit line balances. This offering is registered under an SEC effective registration statement. Alexandria operates in key innovation clusters, focusing on life science, technology, and agtech real estate.
On July 29, 2020, Alexandria Real Estate Equities (ARE) announced a cash tender offer for its outstanding 3.900% Senior Notes due 2023, totaling $500 million. The Offer requires holders to tender their Notes by 5:00 p.m. New York City time on August 4, 2020, with a Settlement Date expected on August 5, 2020. The Company’s acceptance of the Notes is contingent upon the satisfaction of specific conditions, including the proceeds from new unsecured notes. For each $1,000 tendered, the consideration will be based on a fixed spread and U.S. Treasury yields.
Alexandria Real Estate Equities (NYSE:ARE) reported robust financial results for Q2 2020, with total revenues reaching $437 million, a 16.9% increase year-over-year. Net income attributable to common stockholders surged to $226.6 million, marking a significant rise from $76.3 million in Q2 2019. The firm maintains a strong balance sheet with $4.2 billion in liquidity and no debt maturing until 2023. Alexandria remains committed to its dividend strategy, declaring $1.06 per share, reflecting a 6% increase. The company continues to support COVID-19 research through its tenants, emphasizing its vital role in the life sciences sector.
On July 9, 2020, Alexandria Real Estate Equities, Inc. (NYSE: ARE) closed its public offering of 6,900,000 shares of common stock at $160.50 per share, including 900,000 shares from underwriters' options. The company plans to use future proceeds from forward sale agreements for acquisitions, construction of leased projects, and reducing debts, including a $2.2 billion unsecured senior line of credit. The offering was managed by leading financial institutions, enabling Alexandria to establish its market presence further in the life sciences sector.
On July 6, 2020, Alexandria Real Estate Equities (ARE) announced its upsized public offering of 6 million shares at $160.50 each, with an additional 900,000 shares available for underwriters. The offering is set to close on July 9, 2020. This move follows forward sale agreements with major banks, enabling Alexandria to manage share issuance timing while securing cash for upcoming acquisitions and development projects. They are targeting to fund these initiatives using net proceeds from the offering, though they will not receive any immediate proceeds from the sale.
Alexandria Real Estate Equities (NYSE: ARE) announced a public offering of 5,000,000 shares of common stock, with a potential additional 750,000 shares subject to underwriter options. The company will enter forward sale agreements with major banks, expecting settlement by January 6, 2022. Proceeds, if any, will support acquisitions and development projects, alongside reductions in outstanding credit balances. The offering is made under an effective registration statement and does not involve immediate proceeds to the company.
Summary not available.